Real-world efficacy of nivolumab plus cabozantinib in metastatic renal cell carcinoma (mRCC) using the IMDC.Martín Zarbá, Daniel Yick Chin Heng, David Maj et al.|Journal of Clinical Oncology|2026Cited by 0
Real-world analysis of renal cell carcinoma with sarcomatoid differentiation treated with first-line immunotherapy combinations: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).Noelle Thundathil, Daniel Yick Chin Heng, Razane El Hajj Chehade et al.|Journal of Clinical Oncology|2026Cited by 0